This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peraino, C. Articles by Kisieleski, W. E. Search for Related Content PubMed PubMed Citation Articles by Peraino, C. Articles by Kisieleski, W. E.

Effects of Varying the Exposure to Phenobarbital on Its Enhancement of 2-Acetylaminofluorene-induced Hepatic Tumorigenesis in the Rat¹

Division of Biological and Medical Research, Argonne National Laboratory, Argonne, Illinois 60439

In a previous study, phenobarbital feeding enhanced hepatic tumorigenesis in rats previously fed 2-acetylamino-fluorene (AAF). The present study analyzed this enhancement by comparing tumor incidences in rats fed phenobarbital for various periods following a fixed exposure to AAF.

A 5- or 20-day treatment with phenobarbital immediately after cessation of AAF feeding produced little tumorigenic enhancement, in comparison with the severalfold enhancement seen in rats receiving phenobarbital for 100 days and longer. On the other hand, the interposition of a 10- or 30-day interval between the cessation of AAF treatment and the beginning of phenobarbital treatment (which was then continued throughout the experiment) produced exhancement comparable to that produced by beginning the phenobarbital treatment immediately after cessation of AAF feeding. These results indicated that (a) prolonged exposure to phenobarbital was required for tumorigenic enhancement and (b) the tumorigenic lesion produced by AAF was relatively stable, and its expression could be enhanced by phenobarbital long after the cessation of AAF treatment.

Observation of the kinetics of tumor incidence throughout the experiment showed that phenobarbital: (a) decreased the latent period between the end of the carcinogen treatment and the appearance of tumors; (b) increased the growth rate of the tumors; and (c) increased the rate of appearance of new tumor foci. No metastases were seen in rats given AAF alone or followed by phenobarbital, and the morphological characteristics of the tumors were similar with both types of treatment. Phenobarbital, therefore, did not appear to alter the degree of differentiation of the tumors.

¹ This work was supported by the United States Atomic Energy Commission.

Received 6/ 5/73. Accepted 7/18/73.

This article has been cited by other articles:

				R. Simon, E. Lovett 3rd, D Tomaszek, and J Lundy Electrical stimulation of the midbrain mediates metastatic tumor growth Science, September 5, 1980; 209(4461): 1132 - 1133. [Abstract] [PDF]

				G Rovera, T. O'Brien, and L Diamond Induction of differentiation in human promyelocytic leukemia cells by tumor promoters Science, May 25, 1979; 204(4395): 868 - 870. [Abstract] [PDF]

				C. Ehret, V. Potter, and K. Dobra Chronotypic action of theophylline and of pentobarbital as circadian zeitgebers in the rat Science, June 20, 1975; 188(4194): 1212 - 1215. [Abstract] [PDF]